文章核心观点 - 公司的股票估值非常便宜 [1][3][4] - 公司的股息率较高且可持续 [6][7][8][9][12] - 公司的医疗保险业务出现严重下滑是导致整体业绩下滑的主要原因 [15][16][17] - 公司的其他业务如零售药房和PBM业务虽然也有一些负面影响但不是主要问题 [20][21] - 公司有能力通过降低负债比率来提升估值 [22][23] 医疗保险业务分析 - 公司的医疗保险业务毛利率大幅下滑 [15][16][17] - 这主要是由于公司去年在Medicare Advantage业务上定价过于激进导致 [15] - 但这似乎是公司特有的问题而非行业整体问题 [17] - 公司有望通过调整策略来逐步改善这一业务 [17] 其他业务分析 - 公司的零售药房业务受到一定的负面影响 [20][21] - 主要是由于疫情后效应以及亚马逊进入药品配送业务 [20][21] - 但公司有望通过将更多医疗服务整合到门店来应对 [21] - PBM业务虽然受到一些负面舆论影响但不是主要问题 [20] 财务分析 - 公司的负债水平较高但现金流情况良好 [22][23] - 公司有能力通过降低负债来提升估值 [22][23] - 公司的股息率较高且可持续 [6][7][8][9][12]

CVS Health (CVS) ended the recent trading session at $57.98, demonstrating a +0.78% swing from the preceding day's closing price. The stock's change was more than the S&P 500's daily gain of 0.54%. At the same time, the Dow added 0.72%, and the tech-heavy Nasdaq gained 0.65%.Coming into today, shares of the drugstore chain and pharmacy benefits manager had lost 0.05% in the past month. In that same time, the Retail-Wholesale sector gained 9.25%, while the S&P 500 gained 4.86%.Analysts and investors alike wi ...

CVS Health Corporation (CVS) recently introduced hormonal contraceptive prescribing service at CVS Pharmacy locations in Massachusetts. Under the service, a CVS pharmacist will evaluate women interested in receiving a birth control prescription and those who are clinically eligible will receive the same.With the latest launch, the company leaped toward lowering barriers that prevent women from getting the birth control they need. The initiative also helped address the disparities in contraceptive access for ...

CVS pharmacists can now evaluate patients and prescribe hormonal contraceptives WOONSOCKET, R.I., Sept. 12, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) today announced that CVS Pharmacy® locations in Massachusetts are now offering hormonal contraceptive prescribing services. Patients interested in receiving a birth control prescription can be evaluated by a CVS pharmacist and, if clinically eligible, receive a prescription for birth control.CVS pharmacist tests patient's blood pressureCVS pharmacist consul ...

WOONSOCKET, R.I., Sept. 10, 2024 /PRNewswire/ -- CVS Health® (NYSE: CVS) is actively preparing for Tropical Storm Francine, which is expected to make landfall in Louisiana as a hurricane tomorrow. The company's priority is the health and safety of its customers, members and colleagues, and it is committed to providing communities with access to the products and services they need to plan for the storm.CVS Pharmacy® is reaching out to its patients by text message, email and phone to remind them to refill and ...

NEW YORK, Sept. 10, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of CVS Health Corporation (NYSE: CVS). Shareholders who purchased shares of CVS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/cvs-health-corporation-loss-submission-form-2/?id=101234&from=3 CLASS PERIOD: ...

Sundry Photography CVS Health (NYSE:CVS) is a major, American pharmacy, with over 9,000 locations. Earlier this year, its stock took a big tumble after Q1 earnings disappointed. CVS 1Y Price History (Seeking Alpha) While some might have been scared by this, I believe most of the business is sound and that it has proved to be a steady compounder over time. With modest growth assumptions, CVS is priced to deliver attractive returns, which is why I rate it a Buy. Business Model CVS has three main reporting ...

文章核心观点 - CVS Health Corporation(CVS)被指控在2023年5月3日至2024年4月30日期间做出虚假和/或误导性陈述,并未披露以下信息[2][3][4] 1) CVS用于确定计划保费的预测无法有效地考虑医疗成本趋势和医疗服务利用模式 2) 因此,CVS可能会产生大量费用来弥补未在预测中考虑的成本增加,这些成本并未包含在计划保费中 3) 因此,CVS夸大了其医疗保健福利分部的盈利能力 4) 与高管的保证相反,CVS其他主要分部产生的收入不足以抵消医疗保健福利分部支出增加的负面财务影响 根据目录分别总结 案件指控 - 2023年8月2日,CVS公布修订后的每股摊薄收益(EPS)指引范围为6.53美元至6.75美元,此前为6.90美元至7.12美元,并称营业收入"较上年同期下降30.7%,主要是由于医疗保健福利分部的下降"[3] - 2024年2月7日,CVS公布修订后的每股摊薄EPS指引范围为至少7.06美元,此前为至少7.26美元,调整后的每股EPS指引范围为至少8.30美元,此前为至少8.50美元,经营活动产生的现金流指引为至少120亿美元,此前为至少125亿美元[3] - 2024年5月1日,CVS公布收入为884亿美元,低于预期的890亿美元,称更高的医疗服务利用率和Medicare报销率下降将继续对CVS产生压力[4] 原告律师事务所简介 - Robbins Geller Rudman & Dowd LLP是世界领先的复杂集体诉讼事务所之一,专门代表原告处理证券欺诈案件[5] - 过去10年里,该所在ISS证券集体诉讼服务法律事务所排名中位列第一6年,为投资者收回了66亿美元的赔偿,比其他任何律所都多2.2亿美元[5] - 该所拥有200名律师,分布在10个办公室,是世界上最大的原告律所之一,并取得了历史上最大的证券集体诉讼赔付,达72亿美元[5]

It has been about a month since the last earnings report for CVS Health (CVS) . Shares have added about 0.4% in that time frame, underperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is CVS Health due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important drivers. CVS Health Surpasses Q2 Earnings EstimatesCVS He ...

These stocks offer above-average yields ranging between 2.8% and 5.1%.If you've got $5,000 you can afford to invest in the stock market today, there are some good opportunities that can make the most of that money. Not only can you find some good long-term buys trading at cheap valuations, but there are also some safe dividend stocks that are trading near their 52-week lows.Buying dividend stocks at modest valuations can give you the opportunity to lock in higher-than-normal yields while also potentially se ...